A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia

Specified Drug Use-results Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis

This study is to evaluate the safety and the efficacy of Prograf in patients with interstitial pneumonia associated with polymyositis / dermatomyositis in acute clinical setting.

Inclusion Criteria:

• Hospitalized patient
• Patient diagnosed with Interstitial pneumonia associated with polymyositis/dermatomyositis